| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 6 |
| 1 | OMALIZUMAB | 3 |
| 2 | DUPILUMAB | 2 |
| 3 | INSULIN GLARGINE | 2 |
| 4 | LEVOTHYROXINE SODIUM | 2 |
| 5 | PAROXETINE HYDROCHLORIDE | 2 |
| 6 | PREDNISOLONE | 2 |
| 7 | PREDNISOLONE ORAL | 2 |
| 8 | PREDNISOLONE ORAL SOLUTION | 2 |
| 9 | RIVAROXABAN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHENAMINE HIPPURATE | 1 | 0.0008 |
| 1 | LANADELUMAB-FLYO | 1 | 0.0003 |
| 2 | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 3 | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | TASIMELTEON | 1 | 0.0002 |
| 5 | SOTATERCEPT-CSRK | 1 | 0.0002 |
| 6 | IMMUNE GLOBULIN INFUSION (HUMAN) | 1 | 0.0001 |
| 7 | ISONIAZID | 1 | 0.0001 |
| 8 | MERCAPTOPURINE | 1 | 0.0001 |
| 9 | DOXYCLYCLINE HYCLATE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 3 |
| 1 | Corticosteroid [EPC] | 3 |
| 2 | Factor Xa Inhibitor [EPC] | 2 |
| 3 | Human Immunoglobulin G [EPC] | 2 |
| 4 | Insulin Analog [EPC] | 2 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2 |
| 6 | Janus Kinase Inhibitor [EPC] | 2 |
| 7 | Proton Pump Inhibitor [EPC] | 2 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 9 | Antimycobacterial [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 3 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 4 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 5 | Anti-IgE [EPC] | 3 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 9 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |